Recita Lite 0.25 mg/10 mg Tablet
Prescription Required
Introduction of Recita Lite Tablet
Recita Lite 0.25 mg/10 mg Tablet is a prescription medicine used to treat anxiety disorder. It is the combination medicine that calms the brain by decreasing the abnormal and excessive activity of the nerve cells. It also works by increasing the level of a chemical messenger in the brain which improves mood.
Recita Lite 0.25 mg/10 mg Tablet is a combination of two medicines: Recita Lite 0.25 mg/10 mg Tablet1 and Recita Lite 0.25 mg/10 mg Tablet2.
Recita Lite 0.25 mg/10 mg Tablet is a combination of two medicines: Recita Lite 0.25 mg/10 mg Tablet1 and Recita Lite 0.25 mg/10 mg Tablet2.
Uses of Recita Lite Tablet
Benefits of Recita Lite Tablet
In Treatment of Anxiety disorder
Recita Lite 0.25 mg/10 mg Tablet stops your brain from releasing the chemicals that make you feel anxious so it can reduce the symptoms of excessive anxiety and worry. It can also reduce feelings of restlessness, tiredness, difficulty concentrating, feeling irritable and sleep problems that often come with Generalised Anxiety Disorder. Recita Lite 0.25 mg/10 mg Tablet will therefore help you go about your daily activities more easily and be more productive. Keep taking this medicine even if you feel well. Stopping suddenly can cause serious problems.
Side effects of Recita Lite Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Recita Lite
- Delayed ejaculation
- Confusion
- Vomiting
- Memory impairment
- Drowsiness
- Tiredness
- Anorgasmia (decreased orgasm)
- Low sexual desire
- Nausea
- Diarrhea
- Uncoordinated body movements
How to use Recita Lite Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Recita Lite 0.25 mg/10 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Recita Lite 0.25 mg/10 mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Recita Lite 0.25 mg/10 mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Recita Lite 0.25 mg/10 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Recita Lite 0.25 mg/10 mg Tablet may cause side effects which could affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Recita Lite 0.25 mg/10 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Recita Lite 0.25 mg/10 mg Tablet may not be needed in these patients. Please consult your doctor.
Use of Recita Lite 0.25 mg/10 mg Tablet can cause excessive sleepiness in patients with end stage kidney disease.
Use of Recita Lite 0.25 mg/10 mg Tablet can cause excessive sleepiness in patients with end stage kidney disease.
Liver
CAUTION
Recita Lite 0.25 mg/10 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Recita Lite 0.25 mg/10 mg Tablet may be needed. Please consult your doctor.
What if you forget to take Recita Lite Tablet?
If you miss a dose of Recita Lite 0.25 mg/10 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Recita Lite 0.25 mg/10 mg Tablet
₹12.51/Tablet
Nexito LS Tablet
Sun Pharmaceutical Industries Ltd
₹12.7/tablet
2% costlier
Escigress CZ 0.25 Tablet
La Renon Healthcare Pvt Ltd
₹9.7/tablet
22% cheaper
Censpram Lite Tablet
USV Ltd
₹10.2/tablet
18% cheaper
Stalopam Lite Tablet
Lupin Ltd
₹14.25/tablet
14% costlier
Rexipra LS Tablet
Intas Pharmaceuticals Ltd
₹13.1/tablet
5% costlier
Quick tips
Recita Lite Tablet
- Recita Lite 0.25 mg/10 mg Tablet is prescribed for the treatment of anxiety disorder.
- You may feel that Recita Lite 0.25 mg/10 mg Tablet is not helping you straightaway. This is because it can take few weeks before you feel the full benefit. It is important that you continue to take it, even if it takes a little while for your condition to improve.
- If you develop any depressing or suicidal thoughts or ideas, you should let your doctor know about them as soon as possible.
- You might experience low sexual desire after taking Recita Lite 0.25 mg/10 mg Tablet, talk to your doctor if it troubles you.
- Recita Lite 0.25 mg/10 mg Tablet is prescribed for the treatment of anxiety disorder.
- You may feel that Recita Lite 0.25 mg/10 mg Tablet is not helping you straightaway. This is because it can take few weeks before you feel the full benefit. It is important that you continue to take it, even if it takes a little while for your condition to improve.
- If you develop any depressing or suicidal thoughts or ideas, you should let your doctor know about them as soon as possible.
- You might experience low sexual desire after taking Recita Lite 0.25 mg/10 mg Tablet, talk to your doctor if it troubles you.
Fact Box
Habit Forming
Yes
Therapeutic Class
NEURO CNS
Patient concerns
Patient concerns
User feedback
Patients taking Recita Lite 0.25 mg/10 mg Tablet
Once A Day
91%
Twice A Day
9%
What are you using Recita Lite Tablet for?
Depression
100%
FAQs
Recita Lite Tablet
What is Recita Lite 0.25 mg/10 mg Tablet?
Recita Lite 0.25 mg/10 mg Tablet is a combination of two medicines: Clonazepam and Escitalopram. This combination is used to treat anxiety disorders. Clonazepam works by decreasing abnormal electrical activity in the brain. Escitalopram works by increasing the amount of serotonin, a natural substance in the brain that helps to improve mood.
Can the Recita Lite 0.25 mg/10 mg Tablet cause sleepiness or drowsiness?
Recita Lite 0.25 mg/10 mg Tablet may make you feel drowsy or you may fall asleep suddenly during your routine activities like watching television, talking, eating or riding in a car. You might not feel drowsy or have any other warning signs before you suddenly fall asleep. Avoid driving a car, operating machinery, working at heights or participating in potentially dangerous activities at the beginning of your treatment until you know how the medication affects you. Inform your doctor if you experience such symptoms.
Can I take a higher than the recommended dose of this medicine?
No, taking higher than the recommended dose of Recita Lite 0.25 mg/10 mg Tablet can lead to increased chances of side effects and toxicity. If you are experiencing increased severity of your symptoms that is not relieved by the recommended doses, please consult your doctor for re-evaluation.
Any special instruction regarding storage and disposal of Recita Lite 0.25 mg/10 mg Tablet?
Keep Recita Lite 0.25 mg/10 mg Tablet in a container that is tightly closed and out of children's reach. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Unneeded medications should be disposed of in special ways to ensure that pets, children and other people cannot consume them.
Can I stop taking Recita Lite 0.25 mg/10 mg Tablet when my symptoms are relieved?
No, you should not stop taking Recita Lite 0.25 mg/10 mg Tablet even if you feel well. Continue taking your medicine as advised. Your doctor may lower your dose gradually if your symptoms are improving.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
Marketer details
Name: Ipca Laboratories Ltd
Address: 142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present